511PAURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS)
Zhou, C, Wang, M, Cheng, Y, Chen, Y, Zhao, Y, Shi, Y-K, Ahn, M-J, Lu, Y, Shi, M, Han, J-Y, Kim, S-W, Zhang, H-L, Chen, G, Li, H, Wang, J, Wu, Y-LVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy425.022
Date:
November, 2018
File:
PDF, 85 KB
2018
File converter
More search results
More benefits 
